Moore Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Moore Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-109,263	Closed	-$12.3M	–	283
2015 Q4	$12.3M	Buy	+109,263	New	+$11.9M	0.38%	76
2014 Q2	–	Sell	-42,000	Closed	-$3.31M	–	520
2014 Q1	$3.31M	Sell	42,000 -215,988	-84%	-$18M	0.07%	228
2013 Q4	$19.5M	Buy	+257,988	New	+$18.3M	0.31%	63
2013 Q3	–	Sell	-162,000	Closed	-$9.38M	–	390
2013 Q2	$9.38M	Buy	+162,000	New	+$9.36M	0.23%	93

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Moore Capital Management's IBB Position: Q1 2016 in Review

Moore Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 109,263 shares — an estimated $12.3M sold.

Moore Capital Management first reported a position in IBB in Q2 2013 and held it in 4 quarters. The position peaked at $19.5M in Q4 2013. 414 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Moore Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
Moore Capital Management sold 109,263 iShares Biotechnology ETF shares in Q1 2016, an estimated $12.3M.
Moore Capital Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 4 quarters.
Moore Capital Management's iShares Biotechnology ETF position peaked at $19.5M in Q4 2013.
414 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Moore Capital Management's 13F filing for Q1 2016, filed 16 May 2016.